Fingerprint
Dive into the research topics of 'MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
Ankit P. Jain, Krishna Patel, Sneha Pinto, Aneesha Radhakrishnan, Vishalakshi Nanjappa, Manish Kumar, Remya Raja, Arun H. Patil, Anjali Kumari, Malini Manoharan, Coral Karunakaran, Saktivel Murugan, T. S. Keshava Prasad, Xiaofei Chang, Premendu Prakash Mathur, Prashant Kumar, Ravi Gupta, Rohit Gupta, Arati Khanna-Gupta, David Sidransky
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations